PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31596974-1 2019 Innovative monocyclic beta-lactam entities create opportunities in the battle against resistant bacteria because of their PBP acylation potential, intrinsically high beta-lactamase stability and compact scaffold. Monobactams 11-33 dedicator of cytokinesis 3 Homo sapiens 122-125 31596974-7 2019 Furthermore, ring cleavage by representative beta-lactamases was ruled out, providing new insights in the SAR landscape of monocyclic beta-lactams as eligible PBP or beta-lactamase inhibitors. Monobactams 123-146 dedicator of cytokinesis 3 Homo sapiens 159-162